Taken together, our findings might highlight the significance of DDX60L in the tumorigenesis, development and clinical outcome of HCC, and suggest that DDX60L can serve as a prognostic biomarker and therapeutic target for HCC. The gene discussed is DDX60L; the disease is hepatocellular carcinoma.